High prevalence of metabolic syndrome in Iran in comparison with France: What are the components that explain this?

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 3, 2012, Pages 181-188

  Azimi Nezhad, Mohsen ^a   Herbeth, Bernard ^a   Siest, Gérard ^a   Dadé, Sébastien ^a   Ndiaye, Ndeye Coumba ^a   Esmaily, Habibollah ^b   Hosseini, Seyyed Javad ^c   Ghayour Mobarhan, Majid ^c   Visvikis Siest, Sophie ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; FEMALE; FRANCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IRAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; CHOLESTEROL, HDL; CROSS-CULTURAL COMPARISON; FACTOR ANALYSIS, STATISTICAL; FEMALE; FRANCE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; PREVALENCE; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 84861733907     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0097     Document Type: Article

References (54)

1. Miranda PJ, DeFronzo RA, Califf RM, et al. Metabolic syndrome: Definition, pathophysiology, and mechanisms. Am Heart J 2005;149:33-45. (Pubitemid 40126488)
2. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;25;112:2735-2752. (Pubitemid 41532612)
3. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
4. Azizi F, Hadaegh F, Khalili D, et al. Appropriate definition of metabolic syndrome among Iranian adults: Report of the Iranian National Committee of Obesity. Arch Iran Med 2010;13:426-428.
5. Mabry RM, Reeves MM, Eakin EG, et al. Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: A systematic review. Diabet Med 2010;27:593-597.
6. Herbeth B, Samara A, Ndiaye C, et al. Metabolic syndromerelated composite factors over 5 years in the STANISLAS family study: Genetic heritability and common environmental influences. Clin Chim Acta 2010;3;411:833-839.
7. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J 2008;49:571-576.
8. Nezhad MA, Ghayour-Mobarhan M, Parizadeh SM, et al. Metabolic syndrome: Its prevalence and relationship to socio-economic parameters in an Iranian population. Nutr Metab Cardiovasc Dis 2008;18:e11-e12.
9. Azizi F, Salehi P, Etemadi A, et al. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003;61:29-37. (Pubitemid 36808841)
10. Heidari Z, Hosseinpanah F, Mehrabi Y, et al. Predictive power of the components of metabolic syndrome in its development: A 6.5-year follow-up in the Tehran Lipid and Glucose Study (TLGS). Eur J Clin Nutr 2010;64:1207-1214.
11. AnvariMS, BoroumandMA, Pourgholi L, et al. Potential link of microalbuminuria with metabolic syndrome in patients undergoing coronary angiography. Arch Med Res 2009;40:399-405.
12. Delavar MA, Lye MS, Khor GL, et al. Prevalence of metabolic syndrome among middle aged women in Babol, Iran. Southeast Asian J Trop Med Public Health 2009;40:612-628.
13. Delavari A, Forouzanfar MH, Alikhani S, et al. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 2009;32:1092-1097.
14. Ebrahimpour P, Fakhrzadeh H, Pourebrahim R, et al. Metabolic syndrome and related insulin levels in obese children. Metab Syndr Relat Disord 2006;4:172-178. (Pubitemid 44613397)
15. Esmaillzadeh A, Mirmiran P, Azadbakht L, et al. High prevalence of the metabolic syndrome in Iranian adolescents. Obesity (Silver Spring) 2006;14:377-382. (Pubitemid 46219755)
16. Esteghamati A, Khalilzadeh O, Anvari M, et al. Metabolic syndrome and insulin resistance significantly correlate with body mass index. Arch Med Res 2008;39:803-808.
17. Fakhrzadeh H, Ebrahimpour P, Pourebrahim R, et al. Metabolic dyndrome and its associated risk factors in healthy adults: A population-based dtudy in Iran. Metab Syndr Relat Disord 2006,4:28-34.
18. Hadaegh F, Hatami M, Sheikholeslami F, et al. Pulse pressure and systolic blood pressure are powerful independent predictors of cardiovascular disease in diabetic adults: Results of an 8.4 years follow-up of Tehran Lipid and Glucose Study (TLGS). Exp Clin Endocrinol Diabetes 2010;118:638-643.
19. Horri N, Haghighi S, Hosseini SM, et al. Stressful life events, education, and metabolic syndrome in women: Are they related? A study in first-degree relatives of type 2 diabetics. Metab Syndr Relat Disord 2010,8:483-487.
20. Kelishadi R, Gharipour M, Sadri GH, et al. Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population. East Mediterr Health J 2008;14:1070-1079.
21. Kelishadi R, Gouya MM, Adeli K, et al. Factors associated with the metabolic syndrome in a national sample of youths: CASPIAN Study. Nutr Metab Cardiovasc Dis 2008;18: 461-470.
22. Mirhosseini NZ, Yusoff NA, Shahar S, et al. Prevalence of the metabolic syndrome and its influencing factors among adolescent girls in Mashhad, Iran. Asia Pac J Clin Nutr 2009;18:131-136.
23. Nabipour I, Amiri M, Imami SR, et al. The metabolic syndrome and nonfatal ischemic heart disease: A populationbased study. Int J Cardiol 2007;118:48-53. (Pubitemid 46517684)
24. Sadeghian S, Darvish S, Salimi S, et al. Metabolic syndrome: Stronger association with coronary artery disease in young men in comparison with higher prevalence in young women. Coron Artery Dis 2007;18:163-168. (Pubitemid 46608492)
25. Sharifi F, Mousavinasab SN, Soruri R, et al. High prevalence of low high-density lipoprotein cholesterol concentrations and other dyslipidemic phenotypes in an Iranian population. Metab Syndr Relat Disord 2008;6:187-195.
26. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract 2007;77:251-257. (Pubitemid 46671653)
27. Al-Daghri NM. Extremely high prevalence of metabolic syndrome manifestationsamong Arab youth: A call for early intervention. Eur J Clin Invest 2010;40:1063-1066.
28. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, et al. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 2003;26:1781-1785. (Pubitemid 36929119)
29. Kelishadi R. Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiol Rev 2007; 29:62-76. (Pubitemid 47229639)
30. Schwandt P, Kelishadi R, Ribeiro RQ, et al. A threecountry study on the components of the metabolic syndrome in youths: The BIG Study. Int J Pediatr Obes 2010;5: 334-341.
31. Solhpour A, Parkhideh S, Sarrafzadegan N, et al. Levels of lipids and apolipoproteins in three cultures. Atherosclerosis 2009;207:200-207.
32. Koochek A, Mirmiran P, Azizi T, et al. Is migration to Sweden associated with increased prevalence of risk factors for cardiovascular disease? Eur J Cardiovasc Prev Rehabil 2008;15:78-82. (Pubitemid 351263259)
33. Lameira D, Lejeune S, Mourad JJ. [Metabolic syndrome: Epidemiology and its risks]. Ann Dermatol Venereol 2008; 135(Suppl 4):S249-S253. [Article in French]
34. Dallongeville J, Cottel D, Ferrieres J, et al. Household income is associated with the risk of metabolic syndrome in a sexspecific manner. Diabetes Care 2005;28:409-415. (Pubitemid 40170948)
35. Guize L, Thomas F, Pannier B, et al. [Metabolic syndrome: Prevalence, risk factors and mortality in a French population of 62 000 subjects]. Bull Acad Natl Med 2006;190:685-697. [Article in French]
36. Ahluwalia N, Drouet L, Ruidavets JB, et al. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis 2006;186:345-353.
37. Balkau B, Vernay M, Mhamdi L, et al. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab 2003;29:526-532. (Pubitemid 37474265)
38. Bauduceau B, Baigts F, Bordier L, et al. Epidemiology of the metabolic syndrome in 2045 French military personnel (EPIMIL study). Diabetes Metab 2005;31(4 Pt 1):353-359. (Pubitemid 41391477)
39. Bataille V, Perret B, Dallongeville J, et al. Metabolic syndrome and coronary heart disease risk in a population-based study of middle-Aged men from France and Northern Ireland. A nested case-control study from the PRIME cohort. Diabetes Metab 2006;32(5 Pt 1):475-479. (Pubitemid 44836590)
40. Maisonneuve B, Auclair C, Ali M, et al. [Metabolic abnormalities in obese French children]. Arch Pediatr 2009;16:991-998. [Article in French]
41. Maumus S, Marie B, Siest G, et al. A prospective study on the prevalence of metabolic syndrome among healthy French families: Two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-Alpha) are revealed in the offspring of parentswithmetabolic syndrome. DiabetesCare 2005;28:675-682. (Pubitemid 40315331)
42. Pannier B, Thomas F, Eschwege E, et al. Cardiovascular risk markers associated with the metabolic syndrome in a large French population: The ''SYMFONIE'' study. Diabetes Metab 2006;32:467-474. (Pubitemid 44836589)
43. Amini M, Esmaillzadeh A, Shafaeizadeh S, et al. Relationship between major dietary patterns and metabolic syndrome among individuals with impaired glucose tolerance. Nutrition 2010;26:986-992.
44. Brien SE, Ronksley PE, Turner BJ, et al. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: Systematic review and meta-Analysis of interventional studies. BMJ 2011;342:d636.
45. Richard C, Couture P, Desroches S, et al. Effect of the Mediterranean diet with and without weight loss on cardiovascular risk factors in men with the metabolic syndrome. Nutr Metab Cardiovasc Dis 2011;21:628-635.
46. Esmaillzadeh A, Kimiagar M, Mehrabi Y, et al. Dietary patterns and markers of systemic inflammation among Iranian women. J Nutr 2007;137:992-998. (Pubitemid 46596899)
47. Haidari M, Javadi E, Sadeghi B, et al. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem 2001;34:309-315. (Pubitemid 32607574)
48. Kazemi-Bajestani SM, Ghayour-Mobarhan M, Ebrahimi M, et al. reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease. Clin Lab 2007;53:49-56. (Pubitemid 46350982)
49. Chateau-Degat ML, Dewailly E, Poirier P, et al. Comparison of diagnostic criteria of the metabolic syndrome in 3 ethnic groups of Canada. Metabolism 2008;57:1526-1532.
50. Menotti A, Lanti M, Zanchetti A, et al. The role of HDL cholesterol in metabolic syndrome predicting cardiovascular events. The Gubbio population study. Nutr Metab Cardiovasc Dis 2011;21:315-322
51. Haghdoost AA, Sadeghirad B, Rezazadehkermani M. Epidemiology and heterogeneity of hypertension in Iran: A systematic review. Arch Iran Med 2008;11:444-452.
52. Talaei M, Sadeghi M, Marshall T, et al. Impact of metabolic syndrome on ischemic heart disease- A prospective cohort study in an Iranian adult population: Isfahan cohort study. Nutr Metab Cardiovasc Dis 2010 Dec 30 [Epub ahead of print].
53. Kathiresan S, Willer CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009;41:56-65.
54. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26:575-581. (Pubitemid 36929310)